Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
O. Omelyanenko, A. Makarevich, P. Jagus, J. Chorostowska-Wynimko, T. Rybina, E. Amelchenko (Minsk, Belarus; Warsaw, Poland). Copeptin application in severe community-acquired pneumonia (SCAP) severity assessment and outcomes. Eur Respir J 2012; 40: Suppl. 56, 578

Member's Comments

No comment yet.

Related content which might interest you: Biomarkers in severe community-acquired pneumonia (SCAP) prognosis, complications and outcomes Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Procalcitonin and D-dimer to predict prognosis and clinical outcomes in severe community-acquired pneumonia (SCAP) patients Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Biomarkers for the prognostic assessment and disease severity evaluation in community-acquired pneumonia (CAP) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Community-acquired pneumonia (CAP): evaluation of severity criteria for hospitalization Source: Eur Respir J 2003; 22: Suppl. 45, 335s Year: 2003 Management-based risk prediction in community-acquired pneumonia by scores and biomarkers Source: Eur Respir J 2013; 41: 974-984 Year: 2013 Biomarkers and severity in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012 Does the use of the CURB-65 score improve outcomes in community-acquired pneumonia (CAP)? Source: Annual Congress 2009 - Pulmonary infections Year: 2009 Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 42s Year: 2007 Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients? Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia Year: 2006 Inflammatory biomarkers in predicting ICU admission of severe community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Pulmonary infections and sepsis Year: 2011 Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression Source: Eur Respir J 2012; 40: 1201-1210 Year: 2012 Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 D-dimer elevation is associated with severity of community-acquired pneumonia according to CURB-65 and PSI Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 Usefulness of shock index in severity assessment of community-acquired pneumonia Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections Year: 2007 Validation of pneumonia severity models for healthcare-associated pneumonia (HCAP) Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 The assessment of prognostic rules in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 149s Year: 2003 Clinical factors associated with delayed diagnosis in hospitalized community-acquired pneumonia (CAP). Impact on the outcome Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010 Copeptin predicts early clinical deterioration and persistent instability in community-acquired pneumonia Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012 Community-acquired pneumonia (CAP) in the elderly: Prediction of mortality by physical symptoms, laboratory values and radiographic features on admission Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 C-reactive protein as severity biomarker in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 545s Year: 2005